17 years of historical data (2008–2024) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Concord Medical Services Holdings Limited currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $167M | $783328 | $2M | $2M | $3M | $4M | $4M | $5M | $5M | $7M | $7M |
| Enterprise Value | $708M | $3.7B | $3.2B | $3.1B | $2.6B | $2.0B | $1.5B | $539M | $1.1B | $1.0B | $1.0B |
| P/E Ratio → | -0.01 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 2.98 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 |
| P/B Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | 0.18 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 9.68 | 6.03 | 6.53 | 5.31 | 9.07 | 7.33 | 2.82 | 3.47 | 2.21 | 1.69 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | 6.88 |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | 59.95 |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Concord Medical Services Holdings Limited earns an operating margin of -138.6%. Operating margins have compressed from -111.2% to -138.6% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -18.3% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -20.6% | -20.6% | -14.3% | -32.3% | -11.7% | 5.9% | -8.0% | 10.4% | 29.6% | 37.0% | 42.7% |
| Operating Margin | -138.6% | -138.6% | -86.2% | -111.2% | -94.4% | -141.7% | -220.5% | -156.8% | -64.0% | -37.1% | -0.9% |
| Net Profit Margin | -80.3% | -80.3% | -55.4% | -103.7% | -55.9% | -139.0% | -154.8% | -123.0% | -85.9% | -57.5% | -12.7% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -18.3% | -18.3% | -15.8% | -20.6% | -10.6% | -14.5% | -14.8% | -14.3% | -25.3% | -19.6% | -4.8% |
| ROA | -4.8% | -4.8% | -4.9% | -8.0% | -4.7% | -6.4% | -6.9% | -5.8% | -8.5% | -7.7% | -2.4% |
| ROIC | -7.7% | -7.7% | -6.9% | -7.6% | -7.1% | -6.1% | -10.7% | -9.0% | -7.2% | -5.4% | -0.2% |
| ROCE | -12.2% | -12.2% | -10.3% | -10.2% | -8.9% | -7.4% | -11.8% | -9.9% | -9.1% | -7.4% | -0.3% |
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $3.7B ($3.9B total debt minus $216M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.43 | 2.43 | 1.89 | 1.61 | 1.00 | 0.98 | 0.81 | 0.41 | 1.22 | 0.97 | 1.06 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 10.03 |
| Net Debt / Equity | — | 2.30 | 1.85 | 1.53 | 0.94 | 0.84 | 0.77 | 0.23 | 1.13 | 0.81 | 0.72 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 6.83 |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -2.75 | -2.75 | -2.79 | -4.36 | -6.21 | -3.88 | -15.24 | -6.47 | -2.36 | -1.89 | -0.11 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.46x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.68x to 0.46x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.46 | 0.46 | 0.32 | 0.68 | 0.73 | 1.32 | 0.45 | 1.41 | 1.00 | 1.26 | 0.99 |
| Quick Ratio | 0.45 | 0.45 | 0.30 | 0.60 | 0.68 | 1.28 | 0.44 | 1.41 | 1.00 | 1.25 | 0.99 |
| Cash Ratio | 0.17 | 0.17 | 0.03 | 0.14 | 0.20 | 0.65 | 0.12 | 0.52 | 0.09 | 0.20 | 0.42 |
| Asset Turnover | — | 0.06 | 0.09 | 0.08 | 0.08 | 0.04 | 0.05 | 0.04 | 0.10 | 0.14 | 0.17 |
| Inventory Turnover | 13.85 | 13.85 | 15.22 | 7.36 | 14.25 | 9.71 | 49.34 | 50.99 | 37.07 | 48.38 | 90.67 |
| Days Sales Outstanding | — | 48.64 | 49.92 | 100.72 | 287.89 | 307.96 | 222.92 | 388.32 | 326.78 | 241.48 | 227.08 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Concord Medical Services Holdings Limited does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | 100.0% | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% |
| Shares Outstanding | — | $145600 | $145600 | $145600 | $145600 | $145600 | $144700 | $144566 | $144533 | $145133 | $149500 |
Compare CCM with 3 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| CCMYou | $167M | -0.0 | — | — | -20.6% | -138.6% | -18.3% | -7.7% | — |
| FMS | $14B | 11.8 | 6.3 | — | 25.6% | 9.3% | 6.5% | 5.6% | 3.3 |
| DVA | $10B | 17.2 | 9.1 | 8.0 | 27.0% | 14.7% | 46.0% | 10.5% | 5.5 |
| TOI | $219M | -4.1 | — | — | 13.7% | -15.3% | -213.4% | -40.9% | — |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 17 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CCM stacks up against sector leader Fresenius Medical Care AG & Co. KGaA.
Start ComparisonConcord Medical Services Holdings Limited's current P/E ratio is -0.0x. The historical average is 0.9x.
Concord Medical Services Holdings Limited's return on equity (ROE) is -18.3%. The historical average is -7.3%.
Based on historical data, Concord Medical Services Holdings Limited is trading at a P/E of -0.0x. Compare with industry peers and growth rates for a complete picture.
Concord Medical Services Holdings Limited has -20.6% gross margin and -138.6% operating margin.